Levels of serum interleukin (IL)-6, IL-1β, tumour necrosis factor-α and leptin and their correlation in depression

Australian and New Zealand Journal of Psychiatry

Volumn 41, Issue 3, 2007, Pages 266-273

  Yang, Kun ^a,b   Xie, Guangrong ^a   Zhang, Zhongxing ^b   Wang, Changhong ^a,b   Li, Wenbo ^b,c   Zhou, Weiqiang ^b   Tang, Yanqing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c Central Hospital   (China)

Author keywords

Depression; IL 1 ; Interleukin 6 (IL 6); Leptin; Tumor Necrosis Factor (TNF )

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADOLESCENT; ADULT; BODY MASS INDEX; DEPRESSIVE DISORDER; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; PATIENT ADMISSION; REFERENCE VALUES; SEX FACTORS; STATISTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248196593     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670601057759     Document Type: Article

References (44)

1. Antonijevic, IA (2006) Depressive disorders: Is it time to endorse different pathophysiologies?. Psychoneuroendocrinology, 31, pp. 1-15.
2. Simmons, DA and Broderick, PA (2005) Cytokines, stressors, and clinical depression: Augmented adaptation responses underlie depression pathogenesis. Prog Neuropsychopharmacol Biol Psychiatry, 29, pp. 793-807.
3. Marques-Deak, AH, Neto, F Lotufo and Dominguez, WV (2005) Cytokine profiles in women with different subtypes of major depressive disorder. J Psychiatr Res, 41, pp. 152-159.
4. Myint, AM, Leonard, BE, Steinbusch, HW and Kim, YK (2005) Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord, 88, pp. 167-173.
5. Smith, RS. (1991) The macrophage theory of depression. Med Hypotheses, 35, pp. 298-306.
6. Capuron, L. and Miller, AH (2004) Cytokines and psychopathology: Lessons from interferon-alpha. Biol Psychiatry, 56, pp. 819-824.
7. Ushiroyama, T., Ikeda, A. and Ueki, M. (2002) Elevated plasma interleukin-6 (IL-6) and soluble IL-6 receptor concentrations in menopausal women with and without depression. Int J Gynecol Obstetr, 79, pp. 51-52.
8. Kagaya, A., Kugaya, A. and Takebayashi, M. (2001) Plasma concentrations of interleukin-1β, IL-6, sIL-2R and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology, 43, pp. 59-62.
9. Rothermundt, M., Arolt, V. and Peters, M. (2001) Inflammatory markers in major depression and melancholia. J Affect Disord, 63, pp. 93-102.
10. Brambilla, F., Monteleone, P. and Maj, M. (2004) Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia. J Affect Disord, 78, pp. 273-277.
11. Maes, M., Bosmans, E., Meltzer, HY, Scharpe, S. and Suy, E. (1993) Interleukin-1β: A putative mediator of HPA axis hyperactivity in major depression?. Am J Psychiatry, 150, pp. 1189-1193.
12. Maes, M. (1995) Evidence for an immune response in major depression: A review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry, 19, pp. 11-38.
13. Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A. and Kirchner, H. (1995) Cytokine production and serum proteins in depression. Scand J Immunol, 41, pp. 534-538.
14. Weizman, R., Laor, N., Podliszewski, E., Notti, I., Djaldetti, M. and Bessler, H. (1994) Cytokine production in major depressed patients before and after clomipramine treatment. Biol Psychiatry, 35, pp. 42-47.
15. Dubas-slemp, H., Kaminska, T., Marmurowska-Michalowska, H. and Kandefer-Szerszer, M. (2002) Changes in serum concentrations and in cytokine production by blood cell cultures of a patient with major depression: Case report. Ann Univ Marie Curie Sklodowska, 57, pp. 496-504.
16. Sluzewska, A., Rybakowski, J. and Bosmans, E. (1996) Indicators of immune activation in major depression. Psychiatry Res, 64, pp. 161-167.
17. Lanquillon, S., Krieg, JC, Bening-Abu-Shach, U. and Vedder, H. (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology, 22, pp. 370-379.
18. Jequier, E. (2002) Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci, 967, pp. 379-388.
19. Deuschle, M., Blum, WF and Englaro, P. (1996) Plasma leptin in depressed patients and healthy controls. Horm Metab Res, 28, pp. 714-717.
20. Antonijevic, IA, Murck, H., Frieboes, RM, Horn, R., Brabant, G. and Steiger, A. (1998) Elevated nocturnal profiles of serum leptin in patients with depression. J Psychiatr Res, 32, pp. 403-410.
21. Kraus, T., Haack, M., Schuld, A., Hinze, SD and Pollmacher, T. (2001) Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology, 73, pp. 243-247.
22. Rubin, RT, Rhodes, ME and Czambel, RK (2002) Sexual diergism of baseline plasma leptin and leptin suppression by arginine vasopressin in major depressives and matched controls. Psychiatry Res, 113, pp. 255-268.
23. Zhang, MY (1993) The handbook of rating scale in psychiatry branch of study, pp. 81-127. Science and Technology Press
24. Maes, M. (1994) Cytokines in major depression. Biol Psychiatry, 36, pp. 498-499.
25. Musselman, L., Miller, AH and Porter, R. (2001) Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry, 158, pp. 1252-1257.
26. Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A. and Kirchner, H. (1996) Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand, 94, pp. 198-204.
27. Leonard, BE (2001) Changes in the immune system in depression and dementia: Causal or co-incidental effects. Int J Dev Neurosci, 19, pp. 305-312.
28. Wang, J., Grunler, J. and Lewitt, MS (2004) Gender-specific pattern of insulin-like growth factor-binding protein-3 protease activity in mouse thyroid. Endocrinology, 145, pp. 1137-1143.
29. Wichmann, MW, Muller, C. and Meyer, G. (2003) Different immune responses to abdominal surgery in men and women. Langenbecks Arch Surg, 387, pp. 397-401.
30. Haack, M., Hinze-Selch, D. and Fenzel, T. (1999) Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis. J Psychiatr Res, 33, pp. 407-418.
31. Kraus, T., Haack, M., Schuld, A., Hinze, SD, Koethe, D. and Pollmacher, T. (2002) Body weight, tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry, 35, pp. 220-225.
32. Esel, E., Ozsoy, S. and Tutus, A. (2005) Effects of antidepressant treatment and of gender on serum leptin levels in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry, 29, pp. 565-570.
33. Chan, JL, Heist, K., DePaoli, AM, Veldhuis, JD and Mantzoros, CS (2003) The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest, 111, pp. 1409-1421.
34. Prud'homme, GJ and Piccirillo, CA (2000) The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun, 14, pp. 23-42.
35. Meyers, JA, McTiernan, A. and Ulrich, CM (2005) Leptin and immune function: Integrating the evidence. Nutr Res, 25, pp. 791-803.
36. Mohamed-Ali, V., Goodrick, S. and Rawesh, A. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab, 82, pp. 4196-4200.
37. Bastard, JP, Jardel, C., Delattre, J., Hainque, B., Bruckert, E. and Oberlin, F. (1999) Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation, 99, pp. 2221-2222.
38. Bastard, JP, Jardel, C. and Bruckert, E. (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab, 85, pp. 3338-3342.
39. Baumann, H., Morella, KK and White, DW (1996) The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA, 93, pp. 8374-8378.
40. Finck, BN and Johnson, RW (2000) Tumor necrosis factor-alpha regulates secretion of the adipocyte-derived cytokine, leptin. Microsc Res Tech, 50, pp. 209-215.
41. Takahashi, N., Waelput, W. and Guisez, Y. (1999) Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med, 189, pp. 207-212.
42. Kirchgessner, TG, Uysal, KT and Wiesbrock, SM (1997) Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest, 100, pp. 2777-2782.
43. Licinio, J., Negrao, B. and Mantzoros, C. (1998) Sex differences in circulating human leptin pulse amplitude: Clinical implications. J Clin Endocrinol Metab, 83, pp. 4140-4147.
44. Hennessey, J. (2003) Leptin as fat orchestrator. Rev Undergrad Res, 2, pp. 12-18.